Across TCGA pan-cancer cohorts, RNA5SP207 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RNA5SP207 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNA5SP207 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP207 expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.
ACC, TGCT, and KIRC are the cancer types where RNA5SP207 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.